Black Rock Inc. Obs Eva Sa Transaction History

Black Rock Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.83 $1,286 - $16,810	-9,186 Reduced 2.73%	326,829 $47,000
Q2 2022 Aug 12, 2022	SELL	$1.34 - $2.08 $120,549 - $187,120	-89,962 Reduced 21.12%	336,015 $541,000
Q1 2022 May 12, 2022	SELL	$1.1 - $2.17 $83,540 - $164,802	-75,946 Reduced 15.13%	425,977 $643,000
Q4 2021 Feb 10, 2022	BUY	$1.99 - $3.1 $998,826 - $1.56 Million	501,923 New	501,923 $999,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.